Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage [NA]

View source ↗

Summary

A pivotal, prospective, multi-centre, single-arm clinical trial sponsored by Baymatob Operations Pty Ltd to evaluate the safety and effectiveness of Oli for ide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oli

Snippet

Sponsor: Baymatob Operations Pty Ltd | Conditions: Post Partum Haemorrhage, Maternal Care Patterns | NA | Status: RECRUITING